Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPATunity130: Ipatasertib + Paclitaxel in Advanced Breast Cancer
NCT03337724Phase 3Completed
- Sponsor
- Roche
- Start
- Jan 2018
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 30
01
Overview
A Phase 3 trial of ipatasertib in breast cancer, sponsored by Roche. Started Jan 2018; status: completed.
02
Drugs
ipatasertib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03337724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03337724.